The global Gene Delivery System market was valued at US$ 7077.6 million in 2023 and is anticipated to reach US$ 39700 million by 2030, witnessing a CAGR of 27.6% during the forecast period 2024-2030.

Gene Delivery System Market

Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.

Gene Delivery System is widely used for Neurological Diseases, Cancer, etc. The Neurological Diseases occupied about 60% of market share, the cancer occupied about 35%.

North America is the largest consumption place, with a consumption market share nearly 62% in 2019. Following North America, Europe and Asia-Pacific occupied about 35% revenue market share in 2019.

Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen,Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute and etc. are the leaders of the industry. In 2019,top 3 companies occupied over 80% of revenue market share.

This report aims to provide a comprehensive presentation of the global market for Gene Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Delivery System.

Report Scope

The Gene Delivery System market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gene Delivery System companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gene Delivery System Market Report

Report Metric	Details
Report Name	Gene Delivery System Market
Accounted market size in 2023	US$ 7077.6 million
Forecasted market size in 2030	US$ 39700 million
CAGR	27.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Viral Gene Delivery System Non-viral Gene Delivery System
Segment by Application	Neurological Diseases Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Delivery System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Gene Delivery System Market growing?

Ans: The Gene Delivery System Market witnessing a CAGR of 27.6% during the forecast period 2024-2030.

What is the Gene Delivery System Market size in 2030?

Ans: The Gene Delivery System Market size in 2030 will be US$ 39700 million.

What is the Gene Delivery System Market share by application?

Ans: The Neurological Diseases occupied about 60% of market share, the cancer occupied about 35%.

What is the Gene Delivery System Market share by region?

Ans: North America is the largest consumption place, with a consumption market share nearly 62% in 2019.

Who are the main players in the Gene Delivery System Market report?

Ans: The main players in the Gene Delivery System Market are Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute

What are the Application segmentation covered in the Gene Delivery System Market report?

Ans: The Applications covered in the Gene Delivery System Market report are Neurological Diseases, Cancer, Others

What are the Type segmentation covered in the Gene Delivery System Market report?

Ans: The Types covered in the Gene Delivery System Market report are Viral Gene Delivery System, Non-viral Gene Delivery System

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gene Delivery System Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Viral Gene Delivery System

1.2.3 Non-viral Gene Delivery System

1.3 Market by Application

1.3.1 Global Gene Delivery System Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Neurological Diseases

1.3.3 Cancer

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gene Delivery System Market Perspective (2019-2030)

2.2 Gene Delivery System Growth Trends by Region

2.2.1 Global Gene Delivery System Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Gene Delivery System Historic Market Size by Region (2019-2024)

2.2.3 Gene Delivery System Forecasted Market Size by Region (2025-2030)

2.3 Gene Delivery System Market Dynamics

2.3.1 Gene Delivery System Industry Trends

2.3.2 Gene Delivery System Market Drivers

2.3.3 Gene Delivery System Market Challenges

2.3.4 Gene Delivery System Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gene Delivery System Players by Revenue

3.1.1 Global Top Gene Delivery System Players by Revenue (2019-2024)

3.1.2 Global Gene Delivery System Revenue Market Share by Players (2019-2024)

3.2 Global Gene Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Gene Delivery System Revenue

3.4 Global Gene Delivery System Market Concentration Ratio

3.4.1 Global Gene Delivery System Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gene Delivery System Revenue in 2023

3.5 Gene Delivery System Key Players Head office and Area Served

3.6 Key Players Gene Delivery System Product Solution and Service

3.7 Date of Enter into Gene Delivery System Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Delivery System Breakdown Data by Type

4.1 Global Gene Delivery System Historic Market Size by Type (2019-2024)

4.2 Global Gene Delivery System Forecasted Market Size by Type (2025-2030)

5 Gene Delivery System Breakdown Data by Application

5.1 Global Gene Delivery System Historic Market Size by Application (2019-2024)

5.2 Global Gene Delivery System Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Gene Delivery System Market Size (2019-2030)

6.2 North America Gene Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Gene Delivery System Market Size by Country (2019-2024)

6.4 North America Gene Delivery System Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gene Delivery System Market Size (2019-2030)

7.2 Europe Gene Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Gene Delivery System Market Size by Country (2019-2024)

7.4 Europe Gene Delivery System Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Gene Delivery System Market Size (2019-2030)

8.2 Asia-Pacific Gene Delivery System Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Gene Delivery System Market Size by Region (2019-2024)

8.4 Asia-Pacific Gene Delivery System Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Gene Delivery System Market Size (2019-2030)

9.2 Latin America Gene Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Gene Delivery System Market Size by Country (2019-2024)

9.4 Latin America Gene Delivery System Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gene Delivery System Market Size (2019-2030)

10.2 Middle East & Africa Gene Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Gene Delivery System Market Size by Country (2019-2024)

10.4 Middle East & Africa Gene Delivery System Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Biogen

11.1.1 Biogen Company Detail

11.1.2 Biogen Business Overview

11.1.3 Biogen Gene Delivery System Introduction

11.1.4 Biogen Revenue in Gene Delivery System Business (2019-2024)

11.1.5 Biogen Recent Development

11.2 Novartis

11.2.1 Novartis Company Detail

11.2.2 Novartis Business Overview

11.2.3 Novartis Gene Delivery System Introduction

11.2.4 Novartis Revenue in Gene Delivery System Business (2019-2024)

11.2.5 Novartis Recent Development

11.3 Gilead Sciences

11.3.1 Gilead Sciences Company Detail

11.3.2 Gilead Sciences Business Overview

11.3.3 Gilead Sciences Gene Delivery System Introduction

11.3.4 Gilead Sciences Revenue in Gene Delivery System Business (2019-2024)

11.3.5 Gilead Sciences Recent Development

11.4 Sarepta Therapeutics

11.4.1 Sarepta Therapeutics Company Detail

11.4.2 Sarepta Therapeutics Business Overview

11.4.3 Sarepta Therapeutics Gene Delivery System Introduction

11.4.4 Sarepta Therapeutics Revenue in Gene Delivery System Business (2019-2024)

11.4.5 Sarepta Therapeutics Recent Development

11.5 Alnylam Pharmaceuticals

11.5.1 Alnylam Pharmaceuticals Company Detail

11.5.2 Alnylam Pharmaceuticals Business Overview

11.5.3 Alnylam Pharmaceuticals Gene Delivery System Introduction

11.5.4 Alnylam Pharmaceuticals Revenue in Gene Delivery System Business (2019-2024)

11.5.5 Alnylam Pharmaceuticals Recent Development

11.6 Amgen

11.6.1 Amgen Company Detail

11.6.2 Amgen Business Overview

11.6.3 Amgen Gene Delivery System Introduction

11.6.4 Amgen Revenue in Gene Delivery System Business (2019-2024)

11.6.5 Amgen Recent Development

11.7 Spark Therapeutics

11.7.1 Spark Therapeutics Company Detail

11.7.2 Spark Therapeutics Business Overview

11.7.3 Spark Therapeutics Gene Delivery System Introduction

11.7.4 Spark Therapeutics Revenue in Gene Delivery System Business (2019-2024)

11.7.5 Spark Therapeutics Recent Development

11.8 Akcea Therapeutics

11.8.1 Akcea Therapeutics Company Detail

11.8.2 Akcea Therapeutics Business Overview

11.8.3 Akcea Therapeutics Gene Delivery System Introduction

11.8.4 Akcea Therapeutics Revenue in Gene Delivery System Business (2019-2024)

11.8.5 Akcea Therapeutics Recent Development

11.9 bluebird bio

11.9.1 bluebird bio Company Detail

11.9.2 bluebird bio Business Overview

11.9.3 bluebird bio Gene Delivery System Introduction

11.9.4 bluebird bio Revenue in Gene Delivery System Business (2019-2024)

11.9.5 bluebird bio Recent Development

11.10 Sunway Biotech

11.10.1 Sunway Biotech Company Detail

11.10.2 Sunway Biotech Business Overview

11.10.3 Sunway Biotech Gene Delivery System Introduction

11.10.4 Sunway Biotech Revenue in Gene Delivery System Business (2019-2024)

11.10.5 Sunway Biotech Recent Development

11.11 SIBIONO

11.11.1 SIBIONO Company Detail

11.11.2 SIBIONO Business Overview

11.11.3 SIBIONO Gene Delivery System Introduction

11.11.4 SIBIONO Revenue in Gene Delivery System Business (2019-2024)

11.11.5 SIBIONO Recent Development

11.12 AnGes

11.12.1 AnGes Company Detail

11.12.2 AnGes Business Overview

11.12.3 AnGes Gene Delivery System Introduction

11.12.4 AnGes Revenue in Gene Delivery System Business (2019-2024)

11.12.5 AnGes Recent Development

11.13 Orchard Therapeutics

11.13.1 Orchard Therapeutics Company Detail

11.13.2 Orchard Therapeutics Business Overview

11.13.3 Orchard Therapeutics Gene Delivery System Introduction

11.13.4 Orchard Therapeutics Revenue in Gene Delivery System Business (2019-2024)

11.13.5 Orchard Therapeutics Recent Development

11.14 Human Stem Cells Institute

11.14.1 Human Stem Cells Institute Company Detail

11.14.2 Human Stem Cells Institute Business Overview

11.14.3 Human Stem Cells Institute Gene Delivery System Introduction

11.14.4 Human Stem Cells Institute Revenue in Gene Delivery System Business (2019-2024)

11.14.5 Human Stem Cells Institute Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Gilead Sciences

Sarepta Therapeutics

Alnylam Pharmaceuticals

Human Stem Cells Institute

Novartis

Biogen

List of Tables

Table 1. Global Gene Delivery System Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Viral Gene Delivery System

Table 3. Key Players of Non-viral Gene Delivery System

Table 4. Global Gene Delivery System Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Gene Delivery System Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Gene Delivery System Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Gene Delivery System Market Share by Region (2019-2024)

Table 8. Global Gene Delivery System Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Gene Delivery System Market Share by Region (2025-2030)

Table 10. Gene Delivery System Market Trends

Table 11. Gene Delivery System Market Drivers

Table 12. Gene Delivery System Market Challenges

Table 13. Gene Delivery System Market Restraints

Table 14. Global Gene Delivery System Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Gene Delivery System Market Share by Players (2019-2024)

Table 16. Global Top Gene Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Delivery System as of 2023)

Table 17. Ranking of Global Top Gene Delivery System Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Gene Delivery System Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Gene Delivery System Product Solution and Service

Table 21. Date of Enter into Gene Delivery System Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Gene Delivery System Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Gene Delivery System Revenue Market Share by Type (2019-2024)

Table 25. Global Gene Delivery System Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Gene Delivery System Revenue Market Share by Type (2025-2030)

Table 27. Global Gene Delivery System Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Gene Delivery System Revenue Market Share by Application (2019-2024)

Table 29. Global Gene Delivery System Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Gene Delivery System Revenue Market Share by Application (2025-2030)

Table 31. North America Gene Delivery System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Gene Delivery System Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Gene Delivery System Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Gene Delivery System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Gene Delivery System Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Gene Delivery System Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Gene Delivery System Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Gene Delivery System Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Gene Delivery System Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Gene Delivery System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Gene Delivery System Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Gene Delivery System Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Gene Delivery System Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Gene Delivery System Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Gene Delivery System Market Size by Country (2025-2030) & (US$ Million)

Table 46. Biogen Company Detail

Table 47. Biogen Business Overview

Table 48. Biogen Gene Delivery System Product

Table 49. Biogen Revenue in Gene Delivery System Business (2019-2024) & (US$ Million)

Table 50. Biogen Recent Development

Table 51. Novartis Company Detail

Table 52. Novartis Business Overview

Table 53. Novartis Gene Delivery System Product

Table 54. Novartis Revenue in Gene Delivery System Business (2019-2024) & (US$ Million)

Table 55. Novartis Recent Development

Table 56. Gilead Sciences Company Detail

Table 57. Gilead Sciences Business Overview

Table 58. Gilead Sciences Gene Delivery System Product

Table 59. Gilead Sciences Revenue in Gene Delivery System Business (2019-2024) & (US$ Million)

Table 60. Gilead Sciences Recent Development

Table 61. Sarepta Therapeutics Company Detail

Table 62. Sarepta Therapeutics Business Overview

Table 63. Sarepta Therapeutics Gene Delivery System Product

Table 64. Sarepta Therapeutics Revenue in Gene Delivery System Business (2019-2024) & (US$ Million)

Table 65. Sarepta Therapeutics Recent Development

Table 66. Alnylam Pharmaceuticals Company Detail

Table 67. Alnylam Pharmaceuticals Business Overview

Table 68. Alnylam Pharmaceuticals Gene Delivery System Product

Table 69. Alnylam Pharmaceuticals Revenue in Gene Delivery System Business (2019-2024) & (US$ Million)

Table 70. Alnylam Pharmaceuticals Recent Development

Table 71. Amgen Company Detail

Table 72. Amgen Business Overview

Table 73. Amgen Gene Delivery System Product

Table 74. Amgen Revenue in Gene Delivery System Business (2019-2024) & (US$ Million)

Table 75. Amgen Recent Development

Table 76. Spark Therapeutics Company Detail

Table 77. Spark Therapeutics Business Overview

Table 78. Spark Therapeutics Gene Delivery System Product

Table 79. Spark Therapeutics Revenue in Gene Delivery System Business (2019-2024) & (US$ Million)

Table 80. Spark Therapeutics Recent Development

Table 81. Akcea Therapeutics Company Detail

Table 82. Akcea Therapeutics Business Overview

Table 83. Akcea Therapeutics Gene Delivery System Product

Table 84. Akcea Therapeutics Revenue in Gene Delivery System Business (2019-2024) & (US$ Million)

Table 85. Akcea Therapeutics Recent Development

Table 86. bluebird bio Company Detail

Table 87. bluebird bio Business Overview

Table 88. bluebird bio Gene Delivery System Product

Table 89. bluebird bio Revenue in Gene Delivery System Business (2019-2024) & (US$ Million)

Table 90. bluebird bio Recent Development

Table 91. Sunway Biotech Company Detail

Table 92. Sunway Biotech Business Overview

Table 93. Sunway Biotech Gene Delivery System Product

Table 94. Sunway Biotech Revenue in Gene Delivery System Business (2019-2024) & (US$ Million)

Table 95. Sunway Biotech Recent Development

Table 96. SIBIONO Company Detail

Table 97. SIBIONO Business Overview

Table 98. SIBIONO Gene Delivery System Product

Table 99. SIBIONO Revenue in Gene Delivery System Business (2019-2024) & (US$ Million)

Table 100. SIBIONO Recent Development

Table 101. AnGes Company Detail

Table 102. AnGes Business Overview

Table 103. AnGes Gene Delivery System Product

Table 104. AnGes Revenue in Gene Delivery System Business (2019-2024) & (US$ Million)

Table 105. AnGes Recent Development

Table 106. Orchard Therapeutics Company Detail

Table 107. Orchard Therapeutics Business Overview

Table 108. Orchard Therapeutics Gene Delivery System Product

Table 109. Orchard Therapeutics Revenue in Gene Delivery System Business (2019-2024) & (US$ Million)

Table 110. Orchard Therapeutics Recent Development

Table 111. Human Stem Cells Institute Company Detail

Table 112. Human Stem Cells Institute Business Overview

Table 113. Human Stem Cells Institute Gene Delivery System Product

Table 114. Human Stem Cells Institute Revenue in Gene Delivery System Business (2019-2024) & (US$ Million)

Table 115. Human Stem Cells Institute Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Gene Delivery System Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Gene Delivery System Market Share by Type: 2023 VS 2030

Figure 3. Viral Gene Delivery System Features

Figure 4. Non-viral Gene Delivery System Features

Figure 5. Global Gene Delivery System Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Gene Delivery System Market Share by Application: 2023 VS 2030

Figure 7. Neurological Diseases Case Studies

Figure 8. Cancer Case Studies

Figure 9. Others Case Studies

Figure 10. Gene Delivery System Report Years Considered

Figure 11. Global Gene Delivery System Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Gene Delivery System Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Gene Delivery System Market Share by Region: 2023 VS 2030

Figure 14. Global Gene Delivery System Market Share by Players in 2023

Figure 15. Global Top Gene Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Delivery System as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Gene Delivery System Revenue in 2023

Figure 17. North America Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Gene Delivery System Market Share by Country (2019-2030)

Figure 19. United States Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Gene Delivery System Market Share by Country (2019-2030)

Figure 23. Germany Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Gene Delivery System Market Share by Region (2019-2030)

Figure 31. China Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Gene Delivery System Market Share by Country (2019-2030)

Figure 39. Mexico Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Gene Delivery System Market Share by Country (2019-2030)

Figure 43. Turkey Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Biogen Revenue Growth Rate in Gene Delivery System Business (2019-2024)

Figure 46. Novartis Revenue Growth Rate in Gene Delivery System Business (2019-2024)

Figure 47. Gilead Sciences Revenue Growth Rate in Gene Delivery System Business (2019-2024)

Figure 48. Sarepta Therapeutics Revenue Growth Rate in Gene Delivery System Business (2019-2024)

Figure 49. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Delivery System Business (2019-2024)

Figure 50. Amgen Revenue Growth Rate in Gene Delivery System Business (2019-2024)

Figure 51. Spark Therapeutics Revenue Growth Rate in Gene Delivery System Business (2019-2024)

Figure 52. Akcea Therapeutics Revenue Growth Rate in Gene Delivery System Business (2019-2024)

Figure 53. bluebird bio Revenue Growth Rate in Gene Delivery System Business (2019-2024)

Figure 54. Sunway Biotech Revenue Growth Rate in Gene Delivery System Business (2019-2024)

Figure 55. SIBIONO Revenue Growth Rate in Gene Delivery System Business (2019-2024)

Figure 56. AnGes Revenue Growth Rate in Gene Delivery System Business (2019-2024)

Figure 57. Orchard Therapeutics Revenue Growth Rate in Gene Delivery System Business (2019-2024)

Figure 58. Human Stem Cells Institute Revenue Growth Rate in Gene Delivery System Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Microcarrier Bioreactor Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-4O8609

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Immunohistochemistry Reagent Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-25I8231

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global RNA Analysis & Transcriptomic Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2M4266

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global PCR Tubes And PCR Plates Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-38E8328

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions